Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat for Sarcoidosis Associated Pulmonary Hypertension
NCT02625558Phase 4Unknown
- Sponsor
- University of Cincinnati
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of riociguat in pulmonary hypertension (PH), sponsored by University of Cincinnati. Status: unknown.
02
Drugs
riociguat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02625558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625558.